Cedazuridine-impurities | Pharmaffiliates

Cedazuridine

Decitabine/cedazuridine, sold under the brand name Inqovi, is a fixed-dose combination medication for the treatment of adults with myelodysplastic syndromes and chronic myelomonocytic leukemia. Reference standards of Cedazuridine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Cedazuridine - API Standards 
    [catalogue_number] => PA 03 4460000
    [category_ids] => ,76,78,70,82,
    [chemical_name] => 
    [weight] => 266.2
    [form] => C9H12F2N2O5
    [cas] => 1141397-80-9
    [pslug] => 1141397-80-9-cedazuridine-api-pa034460000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 03 4460000

Cedazuridine - API Standards


  • Catalogue No.:PA 03 4460000

  • CAS :

    1141397-80-9

  • Molecular Formula : C9H12F2N2O5

  • Molecular Weight : 266.2